Table 3.

- Multivariate analysis for the factors that are potentially associated with diabetic retinopathy by risk group.

	Low-risk(HbA1c ≤7)				High-risk(HbA1c ≥9)
	aOR	LowerCI	UpperCI	P-value	aOR	LowerCI	Upper CI	P-value
Age	1.012	0.990	1.036	0.284	0.970	0.911	1.033	0.338
BMI	1.014	0.968	1.061	0.566	1.021	0.917	1.137	0.701
Gender	0.611	0.359	1.040	0.069	1.123	0.304	4.151	0.862
SBP	1.008	0.992	1.024	0.340	0.996	0.959	1.034	0.825
DBP	0.988	0.964	1.013	0.340	1.028	0.967	1.094	0.375
HbA1c (last 12 months)	0.712	0.383	1.321	0.281	1.096	0.645	1.863	0.733
LDL	1.007	0.712	1.423	0.970	1.145	0.564	2.328	0.708
Albumin to creatinine ratio	0.993	0.972	1.014	0.485	1.225	0.781	1.923	0.377
Diabetes duration	1.025	0.989	1.062	0.173	0.998	0.915	1.090	0.972
ACEI/ARB use	0.819	0.416	1.609	0.562	1.524	0.305	7.626	0.608
Annual eGFR	0.997	0.985	1.009	0.593	0.992	0.965	1.020	0.555

Abbreviations, as in Table 2; aOR: adjusted odds ratio, CI: confidence interval, LDL: low-density lipoprotein, DBP: diastolic blood pressure, HbA1c: hemoglobin A1c, ACEI: angiotensin converting enzyme inhibitors, ARBs: angiotensin-receptor blockers, BMI: body mass index, SBP: systolic blood pressure,